New public test results since the last issue. Source: Finnrick’s public data summary, latest test 27 Oct 2026. Results are information, not endorsements or medical advice.
The headline
107 new tests across 13 peptides. Running total: 12,729 tests on 35 peptides, 70% passing Finnrick’s default standard.
New results by peptide
| Peptide | New tests | Passed | Failed | All tests | Overall pass rate |
|---|---|---|---|---|---|
| Retatrutide | 58 | 39 | 19 | 4,709 | 77% |
| Tirzepatide | 17 | 13 | 4 | 2,862 | 78% |
| Tesamorelin | 10 | 8 | 2 | 753 | 48% |
| GHK-Cu | 5 | 3 | 2 | 1,006 | 85% |
| BPC-157 | 5 | 4 | 1 | 943 | 50% |
| Ipamorelin | 4 | 1 | 3 | 458 | 67% |
| TB-500 | 2 | 1 | 1 | 295 | 39% |
| CJC-1295 | 1 | 1 | 0 | 338 | 29% |
| MOTS-c | 1 | 1 | 0 | 88 | 35% |
| NAD+ | 1 | 0 | 1 | 72 | 24% |
| KLOW | 1 | 1 | 0 | 23 | too few |
| SS-31 | 1 | 1 | 0 | 23 | too few |
| Glutathione | 1 | 1 | 0 | 8 | too few |
Comment
- Of the new tests that could be scored, 69% passed (74 passed, 33 failed).
- Most new results were for Retatrutide (58 tests).
- Glutathione’s overall pass rate rose from 50% to 60%.
- KLOW’s overall pass rate rose from 72% to 74%.
- Reminder: a pass means the powder matched its label on the day it was tested (purity at least 99.5%, fill within 35%). It says nothing about endotoxin unless that test was ordered, and nothing about a different batch.
How to check a certificate, and what each test measures: Peptide Testing.
genetec.io does not sell peptides, recommend vendors or link to shops. Most of these products are not registered medicines in South Africa or the United States; speak to a registered doctor before using any of them.